RECRUITING

Compliant Analysis of Patient Samples and Data

Description

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Study Overview

Study Details

Study overview

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Use of Patient Samples and Corresponding Clinical Data for Research and Development Studies And/or Population-based Analysis

Compliant Analysis of Patient Samples and Data

Condition
Pregnancy Related
Intervention / Treatment

-

Contacts and Locations

San Diego

Sequenom, Inc, San Diego, California, United States, 92121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Arm 1
  • * All samples and data are de-identified and HIPAA compliant
  • * Arm 2
  • * Subject is of scientific interest to the Sponsor or treating physician
  • * Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.
  • * Arm 1
  • * Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
  • * Arm 2
  • * Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Sequenom, Inc.,

Graham P McLennan, PRINCIPAL_INVESTIGATOR, Sequenom, Inc.

Study Record Dates

2030-08-15